The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc. ("EPS"): | | | | | | | | | | | | | Three Months Ended September 30, | | (in millions, except per share amounts) | 2026 | | 2025 | | Net earnings | $ | 556 | | | $ | 454 | | | Net earnings attributable to noncontrolling interest | (2) | | | (4) | | | Net earnings attributable to Cardinal Health, Inc. | $ | 554 | | | $ | 450 | | | Weighted-average common shares–basic | 232 | | | 238 | | | Effect of dilutive securities: | | | | | Employee stock options, restricted share units, and performance share units | 1 | | | 1 | | | Weighted-average common shares–diluted | 233 | | | 239 | | | Basic earnings per common share attributable to Cardinal Health, Inc.: | $ | 2.39 | | | $ | 1.89 | | | Diluted earnings per common share attributable to Cardinal Health, Inc.: | $ | 2.38 | | | $ | 1.88 | |
|